Stuart Bunting
11Patents
4h-index
17Co-inventors
57Inventor score
Filing activity: Apr 15, 1994 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5935924A | Treatment of congestive heart failure | Human Necessities | 59 | Expired |
| US7371384B2 | Compositions and methods of using angiopoietin-like 4 protein antibody | Chemistry; Metallurgy | 14 | Expired |
| US10512675B2 | Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same | Physics | 6 | Active |
| US8633155B2 | Methods of using angiopoietin-like 4 protein to stimulate proliferation of pre-adipocytes | Chemistry; Metallurgy | 4 | Active |
| US10646550B2 | Use of C-type natriuretic peptide variants to treat skeletal dysplasia | Human Necessities | 4 | Active |
| US6133234A | Methods and compositions for treating vascular stenosis | Human Necessities | 1 | Expired |
| US9907834B2 | Use of C-type natriuretic peptide variants to treat skeletal dysplasia | Human Necessities | 1 | Active |
| US11590204B2 | Use of C-type natriuretic peptide variants to treat skeletal dysplasia | Human Necessities | 0 | Active |
| US11690898B2 | Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same | Physics | 0 | Active |
| US12076372B2 | Use of C-type natriuretic peptide variants to treat skeletal dysplasia | Human Necessities | 0 | Active |
| US11911446B2 | Use of C-type natriuretic peptide variants to treat skeletal dysplasia | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.